Acknowledgement
Supported by : Korea Science and Engineering Foundation
References
- Bernton, E. W., Meltzer, M. S., and Holaday, J. W. (1988) Suppression of macrophage activation and lymphocyte function in hypoprolactinemic mice. Science 239, 401−404
- Berry, S. J., Coffey, D. S., Walsh, P. C., and Ewing, L. L. (1984) The development of human benign prostatic hyperplasia with age. J. Urol. 132, 474−479
- Binart, N., Melaine, N., Pineau, C., Kercret, H., Touzalin, A. M., et al. (2003) Male reproductive function is not affected in prolactin receptor-deficient mice. Endocrinology 144, 3779− 3782 https://doi.org/10.1210/en.2003-0409
- Bole-Feysor, C., Goffin, V., Edery, M., Binart, N., and Kelly, P. A. (1998) Prolactn (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Rev. 19, 225−268 https://doi.org/10.1210/er.19.3.225
- Bouchard, B., Ormandy, C. J., Di Santo, J. P., and Kelly, P. A. (1999) Immune system development and function in prolactin receptor-deficient mice. J. Immunol. 163, 576−582
- Boutin, J.-M., Jolicoeur, C., Okamura, H., Gagnon, J., Edery, M., et al. (1988) Cloning and gene expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53, 69−77 https://doi.org/10.1016/0092-8674(88)90488-6
-
Cho, B. N., McMullen, M. L., Pei, L., Yates, C. J., and Mayo, E. K. (2001) Reproductive deficiencies in the transgenic mice expressing the rat inhibin
$\alpha$ -subunit gene. Endocrinology 142, 4994−5004 https://doi.org/10.1210/en.142.11.4994 - Clapp, C., Martial, J. A., Guzman, R. C., Rentier-Delrue, F., and Weiner, R. I. (1993) The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133, 1292−1299 https://doi.org/10.1210/en.133.3.1292
- Clevenger, C. V., Russell, D. H., Appasamy, P. M., and Prystowsky, M. B. (1990) Regulation of IL2-driven Tlymphocyte proliferation by prolactin. Proc. Natl. Acad. Sci. USA 87, 6460−6464
- Clevenger, C. V., Altmann, S. W., and Prystowsky, M. B. (1991) Requirement of nuclear prolactin for interleukin-2- stimulated proliferation of T lymphocytes. Science 253, 77−79 https://doi.org/10.1126/science.2063207
- Clevenger, C. V., Sillman, A. L., Hanley-Hyde, J., and Prystowsky, M. B. (1992) Requirement for prolactin during cell cycle regulated gene expressed in cloned T-lymphocytes. Endocrinology 130, 3216−3222 https://doi.org/10.1210/en.130.6.3216
- Clevenger, C. V., Chang, W. P., Ngo, W., Pasha, T. L. M., Montone, K. T., et al. (1995) Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop. Am. J. Pathol. 146, 695−705
- Danko, I., Williams, P., Herweijer, H., Zhang, G., Latendresses, J. S., et al. (1997) High expression of naked plasmid DNA in muscles of young rodents. Hum. Mol. Genet. 6, 1453−1443
- Dombrowicz, D., Sente, B., Closset, J., and Hennen, G. (1992) Dose-dependent effects of human prolactin on the immature hypophysectomized rat testis. Endocrinology 130, 695−700 https://doi.org/10.1210/en.130.2.695
- Elias, K. A. and Weiner, R. L. (1984) Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc. Natl. Acad. Sci. USA 81, 4549−4553
- Ferrara, N., Clapp, C., and Weiner, R. (1991) The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129, 896−900
- Fletcher-Chiappini, S. E., Comptom, M. M., Lavoie, H. A., Day, E. B., and Witorsch, R. J. (1993) Glucocorticoid-prolactin interactions in Nb2 lymphoma cells: antiproliferative versus anticytolytic effects. Proc. Soc. Exp. Biol. Med. 202, 345− 352
- Folkman, J. (1995) Angiogenesis inhibitors generated by tumors. Mol. Med. 1, 120−122
- Gala, R. R. and Shevach, E. M. (1997) The immunomodulatory effects of a recombinant bovine prolactin (rbPRL) are secondary to endotoxin contamination. FASEB. J. 11, 99A
- Ginsberg, E. and Vonderharr, B. K. (1995) Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 55, 2591−2595
- Gunasekar, P. G., Kumaran, B., and Govindarajulu, P. (1988) Prolactin and Leydig cell steroidogenic enzymes in the bonnet monkey (macaca radiata). Int. J. Androl. 11, 53−59
- Hammond, G. L., Kontturi, M., Maattala, P., Puukka, M., and Vihko, R. (1977) Serum FSH, LH and prolactin in normal males and patients with prostatic diseases. Clin. Endocrinol. (Oxf) 7, 129−135
- Hanahan, D. and Folkman, J. (1996) Pattern and emerging mechanism of the angiogenic switch during tumorigenesis. Cell 86, 353−364
- Harper, M. E., Peeling, W. B., Cowley, T., Brownsey, B. G., Philips, M. E. A., et al. (1976) Plasma steroid and protein hormone concentration in patients with prostatic carcinoma, before and during oestrogen therapy. Acta. Endocrinol. (Copenh) 81, 409−426
- Horseman, N. D., Zhao, W., Montecino-Rodriquez, E., Tanaka, M., Nakashima, K., et al. (1997) Defective mammopoiesis, but hematopoiesis, in mice with a targeted disruption of the prolactin gene. EMBO J. 16, 6926−6935 https://doi.org/10.1093/emboj/16.23.6926
- Jackson, D., Volpert, O. V., Bouck, N., and Linzer, D. I. H. (1994) Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 266, 1581−1584 https://doi.org/10.1126/science.7527157
- Kant, G. J., Bauman, R. A., Anderson, S. M., and Mougey, E. H. (1992) Effects of controllable vs. uncontrollable chronic stress on stress-responsive plasma hormones. Physiol. Behav. 51, 1285−1288
- Ko, J.-Y., Ahn, Y.-L., and Cho, B. N. (2003) Angiogenesis and white blood proliferation induced in mice by injection of a prolactin-expressing plasmid into muscle. Mol. Cells 15, 262−270
- Lee, D. W. and Markoff, E. (1986) Synthesis and release of glycosylated prolactin by human deciduas in vitro. J. Clin. Endocrinol. Metab. 62, 990−994
- Lee, C. W., Lee, C. U., Kim, J. H., Son, B. C., Kim, D. H., et al. (2003) Effects of Aroclor 1254 on the expression of rat placental PRL-family genes. Mol. Cells 15, 114−121
- Leong, D. A., Frawley, L. S., and Neill, J. D. (1983) Neuroendocrine control of prolactin secretion. Ann. Rev. Physiol. 45, 109−127
- Loudon, A. S., Brinklow, B. R., Gulland, F. D., Boyle. J., and Flint, A. P. (1990) Roles of prolactin and the uterus in the control of luteal regression in the Bennetts's wallaby (Macropus rufogriseus rufogriseus). Reprod. Fertil. Dev. 2, 71−78
-
Matsuyama, S., Shiota, K., and Takahashi, M. (1990) Possible role of transforming growth factor-
$\beta$ as a mediator of luteotropic action of prolactin in rat luteal cell cultures. Endocrinology 127, 1561−1567 https://doi.org/10.1210/endo-127-4-1561 - Maurer, R. A. (1980) Dopaminergic inhibition of prolactin synthesis and prolactin messenger RNA accumulation in cultured pituitary cells. J. Biol. Chem. 255, 8092−8097
- Maurer, R. A. (1982) Estradiol regulates the transcription of the prolactin gene. J. Biol. Chem. 257, 2133−2136
- Montgomery, D. W., LeFevre, J. A., Ulrich, E. D., Adamson, C. R., and Zukoski, C. F. (1990) Identification of prolactin-like proteins synthesized by normal murine lymphocytes. Endocrinology 127, 2601−2603 https://doi.org/10.1210/endo-127-5-2601
- Neill, J. (1988) Prolactin secretion and its control; in The Physiology of Reproduction, Knobil, E. and Neill, J. (eds.), pp. 1379−1390, Raven Press, New York
- Nevalainen, M. T., Valve, E. M., Ingelton, P. M., Nurmi, M., Martikainen, P. M., et al. (1997) Prolactin and prolactin receptors are expressed and functioning in the human prostate. J. Clin. Invest. 99, 618−627
- Olazabal, I., Munoz, J., Ogueta, S., Obregon, E., and Garcia- Ruiz, J. P. (2000) Prolactin (PRL)-PRL receptor system increases cell proliferation involving JNK (c-Jun amino terminal kinase) and AP-1 activation: Inhibition by glucocorticoids. Mol. Endocrinol. 14, 564?575 https://doi.org/10.1210/me.14.4.564
- Ormandy, C. J., Camus, A., Barra, J., Damotte, D., Lucas, B., et al. (1997) Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Dev. 11, 167−178
- Pellegrini, I., Lebrun, J.-J., Ali, S., and Kelly, P. A. (1992) Expression of prolactin and its receptor in human lymphoid cells. Mol. Endocrinol. 6, 1023−1031 https://doi.org/10.1210/me.6.7.1023
- Raymond, V., Beaulieu, M., Labrie, F., and Boissier, J. (1978) Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Science 200, 1173−1175
- Russell, D. H., Matrisian, L., Kibler, R., Larson, D. F., Poulos, B., et al. (1984) Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem. Biophys. Res. Commun. 121, 899−906
- Saroff, J., Kirdani, R. Y., Chu, M., Wajsman, Z., and Murhpy, G. P. (1980) Measurements of prolactin and androgens in patients with prostatic diseases. Oncology 37, 46−52
- Sinha, Y. N. (1995) Structure variants of prolactin: Occurrence and physiological significance. Endocrine Rev. 16, 354−369
- Steger, R. W., Chandrashekar, V., Zhao, W., Bartke, A., and Horseman, N. D. (1998) Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 139, 3691−3695
- Struman, I., Bentzien, F., Lee, H., Mainfroid, V., D'Angelo, G., et al. (1999) Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis. Proc. Natl. Acad. Sci. USA 96, 1246− 1251
- Walker, A. M., Montgomery, D. W., Saraiya, S., Ho, T. W. C., Garewal, H. S., et al. (1995) Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes. Proc. Natl. Acad. Sci. USA 92, 3278−3282
- Wennbo, H., Kindblom, J., Isaksson, O. G., and Tornell, J. (1997) Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 138, 4410−4415
- Witorsch, R. J., Day, E. B., Lavoie, H. A., Hashemi, N., and Taylor, J. K. (1993) Comparison of glucocorticoid-induced effects in prolactin-dependent and autonomous rat Nb2 lymphoma cells. Proc. Soc. Exp. Biol. Med. 203, 454−460